Developmental programming: Interaction between prenatal bpa exposure and postnatal adiposity on metabolic variables in female sheep

American Journal of Physiology - Endocrinology and Metabolism

Volumn 310, Issue 3, 2016, Pages E238-E247

  Veiga Lopez, Almudena ^a,b   Moeller, Jacob ^a   Sreedharan, Rohit ^a   Singer, Kanakadurga ^a   Lumeng, Carey ^a   Ye, Wen ^a   Pease, Anthony ^b   Padmanabhan, Vasantha ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Adipocytes; Bisphenol A; Development origins and toxicology; Inflammation; Insulin resistance

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; CHLORDANE; BENZHYDRYL DERIVATIVE; CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; ESTROGEN; LEUKOCYTE ANTIGEN; PHENOL DERIVATIVE;

ADIPOCYTE; ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CELL INFILTRATION; CELL SIZE; COHORT ANALYSIS; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FAT MASS; FEMALE; GENETIC SUSCEPTIBILITY; GLUCOSE TOLERANCE TEST; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; MACROPHAGE; MORPHOMETRICS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OUTCOME ASSESSMENT; OVERNUTRITION; POSTNATAL ADIPOSITY; POSTNATAL DEVELOPMENT; POTENTIAL DIFFERENCE; PRENATAL EXPOSURE; PRIORITY JOURNAL; SUBCUTANEOUS FAT; SUFFOLK SHEEP; ANIMAL; DRUG EFFECTS; GENETIC PREDISPOSITION; HYPERTROPHY; IMMUNOLOGY; PATHOLOGY; PREGNANCY; SHEEP; WHITE ADIPOCYTE;

ADIPOCYTES, WHITE; ADIPOSITY; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BENZHYDRYL COMPOUNDS; ESTROGENS, NON-STEROIDAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HYPERTROPHY; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MACROPHAGES; OBESITY; OVERNUTRITION; PHENOLS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SHEEP; SUBCUTANEOUS FAT;

EID: 84956904238     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00425.2015     Document Type: Article

References (55)

1. Alonso-Magdalena P, Vieira E, Soriano S, Menes L, Burks D, Quesada I, Nadal A. Bisphenol A exposure during pregnancy disrupts glucose homeostasis in mothers and adult male offspring. Environ Health Perspect 118: 1243–1250, 2010.
2. Angle BM, Do RP, Ponzi D, Stahlhut RW, Drury BE, Nagel SC, Welshons WV, Besch-Williford CL, Palanza P, Parmigiani S, vom Saal FS, Taylor JA. Metabolic disruption in male mice due to fetal exposure to low but not high doses of bisphenol A (BPA): evidence for effects on body weight, food intake, adipocytes, leptin, adiponectin, insulin and glucose regulation. Reprod Toxicol 42: 256–268, 2013.
3. Arner P, Bernard S, Salehpour M, Possnert G, Liebl J, Steier P, Buchholz BA, Eriksson M, Arner E, Hauner H, Skurk T, Rydén M, Frayn KN, Spalding KL. Dynamics of human adipose lipid turnover in health and metabolic disease. Nature 478: 110–113, 2011.
4. Bunner AE, Chandrasekera PC, Barnard ND. Knockout mouse models of insulin signaling: Relevance past and future. World J Diabetes 5: 146–159, 2014.
5. Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect 116: 39–44, 2008.
6. Caprio S, Plewe G, Diamond MP, Simonson DC, Boulware SD, Sherwin RS, Tamborlane WV. Increased insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity. J Pediatr 114: 963–967, 1989.
7. Dennery PA. Oxidative stress in development: nature or nurture? Free Radic Biol Med 49: 1147–1151, 2010.
8. Desai M, Jellyman JK, Ross MG. Epigenomics, gestational programming and risk of metabolic syndrome. Int J Obes (Lond) 39: 633–641, 2015.
9. Ding S, Fan Y, Zhao N, Yang H, Ye X, He D, Jin X, Liu J, Tian C, Li H, Xu S, Ying C. High-fat diet aggravates glucose homeostasis disorder caused by chronic exposure to bisphenol A. J Endocrinol 221: 167–179, 2014.
10. Drolet R, Richard C, Sniderman AD, Mailloux J, Fortier M, Huot C, Rhéaume C, Tchernof A. Hypertrophy and hyperplasia of abdominal adipose tissues in women. Int J Obes (Lond) 32: 283–291, 2008.
11. Eng DS, Lee JM, Gebremariam A, Meeker JD, Peterson K, Padmanabhan V. Bisphenol A and chronic disease risk factors in US children. Pediatrics 132: e637–e645, 2013.
12. Gerona RR, Woodruff TJ, Dickenson CA, Pan J, Schwartz JM, Sen S, Friesen MW, Fujimoto VY, Hunt PA. Bisphenol-A (BPA), BPA glucuronide, and BPA sulfate in midgestation umbilical cord serum in a northern and central California population. Environ Sci Technol 47: 12477–12485, 2013.
13. Goran MI, Gower BA. Longitudinal study on pubertal insulin resistance. Diabetes 50: 2444–2450, 2001.
14. Habert R, Muczynski V, Grisin T, Moison D, Messiaen S, Frydman R, Benachi A, Delbes G, Lambrot R, Lehraiki A, N’tumba-Byn T, Guerquin MJ, Levacher C, Rouiller-Fabre V, Livera G. Concerns about the widespread use of rodent models for human risk assessments of endocrine disruptors. Reproduction 147: R119–R129, 2014.
15. Harley KG, Aguilar Schall R, Chevrier J, Tyler K, Aguirre H, Bradman A, Holland NT, Lustig RH, Calafat AM, Eskenazi B. Prenatal and postnatal bisphenol A exposure and body mass index in childhood in the CHAMACOS cohort. Environ Health Perspect 121: 514–520, 2013.
16. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 35: 1364–1379, 2012.
17. Jo J, Gavrilova O, Pack S, Jou W, Mullen S, Sumner AE, Cushman SW, Periwal V. Hypertrophy and/or hyperplasia: dynamics of adipose tissue growth. PLoS Comput Biol 5: e1000324, 2009.
18. Kelly LA, Lane CJ, Weigensberg MJ, Toledo-Corral CM, Goran MI. Pubertal changes of insulin sensitivity, acute insulin response, and -cell function in overweight Latino youth. J Pediatr 158: 442–446, 2011.
19. Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 52: 1779–1785, 2003.
20. Lysaght J, van der Stok EP, Allott EH, Casey R, Donohoe CL, Howard JM, McGarrigle SA, Ravi N, Reynolds JV, Pidgeon GP. Pro-inflammatory and tumour proliferative properties of excess visceral adipose tissue. Cancer Lett 312: 62–72, 2011.
21. Madonna R, De Caterina R. Atherogenesis and diabetes: focus on insulin resistance and hyperinsulinemia. Rev Esp Cardiol (Engl Ed) 65: 309–313, 2012.
22. Manikkam M, Crespi EJ, Doop DD, Herkimer C, Lee JS, Yu S, Brown MB, Foster DL, Padmanabhan V. Fetal programming: prenatal testosterone excess leads to fetal growth retardation and postnatal catch-up growth in sheep. Endocrinology 145: 790–798, 2004.
23. Michaud A, Boulet MM, Veilleux A, Noel S, Paris G, Tchernof A. Abdominal subcutaneous and omental adipocyte morphology and its relation to gene expression, lipolysis and adipocytokine levels in women. Metabolism 63: 372–381, 2014.
24. Michaud A, Drolet R, Noel S, Paris G, Tchernof A. Visceral fat accumulation is an indicator of adipose tissue macrophage infiltration in women. Metabolism 61: 689–698, 2012.
25. Miyawaki J, Sakayama K, Kato H, Yamamoto H, Masuno H. Perinatal and postnatal exposure to bisphenol a increases adipose tissue mass and serum cholesterol level in mice. J Atheroscler Thromb 14: 245–252, 2007.
26. Nakagawa S, Cuthill IC. Effect size, confidence interval and statistical significance: a practical guide for biologists. Biol Rev 82: 591–605, 2007.
27. National Center for Chronic Disease Prevention and Health Promotion. Statistics About Diabetes. National Diabetes Statistics Report 2014. Atlanta, GA: Centers for Disease Control and Prevention, 2014, p. 1–12.
28. Nuyt AM. Mechanisms underlying developmental programming of elevated blood pressure and vascular dysfunction: evidence from human studies and experimental animal models. Clin Sci (Lond) 114: 1–17, 2008.
29. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of Childhood and Adult Obesity in the United States, 2011–2012. JAMA 311: 806–814, 2014.
30. Padmanabhan V, Siefert K, Ransom S, Johnson T, Pinkerton J, Anderson L, Tao L, Kannan K. Maternal bisphenol-A levels at delivery: a looming problem? J Perinatol 28: 258–263, 2008.
31. Padmanabhan V, Veiga-Lopez A, Abbott DH, Recabarren SE, Herkimer C. Developmental programming: impact of prenatal testosterone excess and postnatal weight gain on insulin sensitivity index and transfer of traits to offspring of overweight females. Endocrinology 151: 595–605, 2010.
32. Padmanabhan V, Veiga-Lopez A. Animal models of the polycystic ovary syndrome phenotype. Steroids 78: 734–740, 2013.
33. Patel BB, Kasneci A, Bolt AM, Di Lalla V, Di Iorio MR, Raad M, Mann KK, Chalifour LE. Chronic exposure to bisphenol A reduces successful cardiac remodeling after an experimental myocardial infarction in male c57bl/6n mice. Toxicol Sci 146: 101–115, 2015.
34. Peretz J, Vrooman L, Ricke WA, Hunt PA, Ehrlich S, Hauser R, Padmanabhan V, Taylor HS, Swan SH, VandeVoort CA, Flaws JA. Bisphenol a and reproductive health: update of experimental and human evidence, 2007–2013. Environ Health Perspect 122: 775–786, 2014.
35. Pestana D, Faria G, Sa C, Fernandes VC, Teixeira D, Norberto S, Faria A, Meireles M, Marques C, Correia-Sa L, Cunha A, Guimaraes JT, Taveira-Gomes A, Santos AC, Domingues VF, Delerue-Matos C, Monteiro R, Calhau C. Persistent organic pollutant levels in human visceral and subcutaneous adipose tissue in obese individuals— depot differences and dysmetabolism implications. Environ Res 133: 170–177, 2014.
36. Pietilainen KH, Kannisto K, Korsheninnikova E, Rissanen A, Kaprio J, Ehrenborg E, Hamsten A, Yki-Jarvinen H. Acquired obesity increases CD68 and tumor necrosis factor-alpha and decreases adiponectin gene expression in adipose tissue: a study in monozygotic twins. J Clin Endocrinol Metab 91: 2776–2781, 2006.
37. Prins GS, Birch L, Tang WY, Ho SM. Developmental estrogen exposures predispose to prostate carcinogenesis with aging. Reprod Toxicol 23: 374–382, 2007.
38. Ross R, Aru J, Freeman J, Hudson R, Janssen I. Abdominal adiposity and insulin resistance in obese men. Am J Physiol Endocrinol Metab 282: E657–E663, 2002.
39. Roy A, Bauer SM, Lawrence BP. Developmental exposure to bisphenol A modulates innate but not adaptive immune responses to influenza A virus infection. PLoS One 7: e38448, 2012.
40. Rubin BS. Bisphenol A: an endocrine disruptor with widespread exposure and multiple effects. J Steroid Biochem Mol Biol 127: 27–34, 2011.
41. Ryan KK, Haller AM, Sorrell JE, Woods SC, Jandacek RJ, Seeley RJ. Perinatal exposure to bisphenol-a and the development of metabolic syndrome in CD-1 mice. Endocrinology 151: 2603–2612, 2010.
42. Savabieasfahani M, Kannan K, Astapova O, Evans NP, Padmanabhan V. Developmental programming: differential effects of prenatal exposure to bisphenol-A or methoxychlor on reproductive function. Endocrinology 147: 5956–5966, 2006.
43. Somm E, Schwitzgebel VM, Toulotte A, Cederroth CR, Combescure C, Nef S, Aubert ML, Huppi PS. Perinatal exposure to bisphenol a alters early adipogenesis in the rat. Environ Health Perspect 117: 1549–1555, 2009.
44. Spearow J. Reviewer’s appendix to the white paper on species/stock/strain in endocrine disruptor assays. In: Endocrine Disruptor Screening Program. Washington, DC: US Environmental Protection Agency, 2004, p. A1–A97.
45. Steckler TL, Herkimer C, Dumesic DA, Padmanabhan V. Developmental programming: excess weight gain amplifies the effects of prenatal testosterone excess on reproductive cyclicity—implication for polycystic ovary syndrome. Endocrinology 150: 1456–1465, 2009.
46. Tyl RW, Myers CB, Marr MC, Thomas BF, Keimowitz AR, Brine DR, Veselica MM, Fail PA, Chang TY, Seely JC, Joiner RL, Butala JH, Dimond SS, Cagen SZ, Shiotsuka RN, Stropp GD, Waechter JM. Three-generation reproductive toxicity study of dietary bisphenol A in CD Sprague-Dawley rats. Toxicol Sci 68: 121–146, 2002.
47. Valvi D, Casas M, Mendez MA, Ballesteros-Gomez A, Luque N, Rubio S, Sunyer J, Vrijheid M. Prenatal bisphenol A urine concentrations and early rapid growth and overweight risk in the offspring. Epidemiology 24: 791–799, 2013.
48. Vandenberg LN, Hunt PA, Myers JP, Vom Saal FS. Human exposures to bisphenol A: mismatches between data and assumptions. Rev Environ Health 28: 37–58, 2013.
49. Veiga-Lopez A, Luense LJ, Christenson LK, Padmanabhan V. Developmental programming: gestational bisphenol-A treatment alters trajectory of fetal ovarian gene expression. Endocrinology 154: 1873–1884, 2013.
50. Veiga-Lopez A, Moeller J, Patel D, Ye W, Pease A, Kinns J, Padmanabhan V. Developmental programming: impact of prenatal testosterone excess on insulin sensitivity, adiposity, and free fatty acid profile in postpubertal female sheep. Endocrinology 154: 1731–1742, 2013.
51. Veiga-Lopez A, Wurst AK, Steckler TL, Ye W, Padmanabhan V. Developmental programming: postnatal estradiol amplifies ovarian follicular defects induced by fetal exposure to excess testosterone and dihydrotestosterone in sheep. Reprod Sci 21: 444–455, 2014.
52. Veiga-Lopez A, Beckett EM, Abi Salloum B, Ye W, Padmanabhan V. Developmental programming: prenatal BPA treatment disrupts timing of LH surge and ovarian follicular wave dynamics in adult sheep. Toxicol Appl Pharmacol 279: 119–128, 2014.
53. Veiga-Lopez A, Pennathur S, Kannan K, Patisaul HB, Dolinoy DC, Zeng L, Padmanabhan V. Impact of gestational bisphenol A on oxidative stress and free fatty acids: human association and interspecies animal testing studies. Endocrinology 156: 911–922, 2015.
54. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21: 697–738, 2000.
55. Zambrano E, Guzman C, Rodriguez-Gonzalez GL, Durand-Carbajal M, Nathanielsz PW. Fetal programming of sexual development and reproductive function. Mol Cell Endocrinol 382: 538–549, 2014.